Lipitor losses hit Pfizer
May 2, 2012Sales and Marketing Alzheimer's, Lipitor, Pfizer, patent expiry
Lipitor’s US patent expiry has inflicted heavy damage on Pfizer’s revenues, with global sales down 7% in the first three …
SHL to speak & exhibit at the PDA’s upcoming Prefilled Syringe Seminar in Japan
May 2, 2012Manufacturing and Production auto injector, autoinjector, pda japan, prefilled syringe
SHL to speak & exhibit at the PDA’s upcoming Prefilled Syringe Seminar in Tokyo, Japan May 22nd-23rd 2012 Auto injectors …
Targacept cuts workforce
May 1, 2012Research and Development, Sales and Marketing AstraZeneca, MDD, TC-5214, Targecept
The fall-out from pipeline difficulties has led US biopharma company Targacept to make almost half its workforce redundant. In March …
EMA eSubmission Gateway now live
May 1, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing wainwright associates; ectd
Following a successful pilot, the European Medicines Agency (EMA) has announced that its eSubmission Gateway is now live for all …
Novartis will restart production at Lincoln plant in May
May 1, 2012Manufacturing and Production FDA, GMP, Lincoln, Nebraska, Novartis, manufacturing
Novartis chief executive Joe Jimenez has said that production at the firm’s troubled consumer health plant in Lincoln, Nebraska, will …
FDA approves greener process for Januvia production
May 1, 2012Manufacturing and Production Codexis, FDA, Januvia, Merck, manufacturing
The US Food and Drug Administration (FDA) has approved a new, more environmentally-friendly manufacturing process for Merck & Co’s diabetes …
Pharma manufacturing news in brief
May 1, 2012Manufacturing and Production Aptar Pharma, Ark Therapeutics, Cambrex, Eckert & Ziegler, Granules India and Omkar Speciality Chemicals
Cambrex facility passes FDA inspection, low-cost inhaler launched by Aptar, plus updates from Eckert & Ziegler, Granules India and Omkar …
Contract research news in brief
May 1, 2012Research and Development BML, Cetero Labs, Covance, Harlan and Chiltern, PRA
A round-up of recent developments in the contract research sector, featuring updates from PRA, Cetero Labs, Covance/BML, Harlan Labs CRS …
Actelion boosted by trial success
April 30, 2012Research and Development, Sales and Marketing Actelion, Tracleer, almorexant, macitentan
Actelion’s pulmonary arterial hypertension drug macitentan has met its primary endpoint in a Phase III trial. The news comes after …
FDA approves GSK’s Votrient for new licence
April 30, 2012Sales and Marketing Cancer, FDA Approval, GSK, Votrient
The FDA has approved GlaxoSmithKline’s cancer pill Votrient for the treatment of a rare group of cancers – but has …
New ABPI president appointed
April 30, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, MSD UK, appointment
Deepak Khanna, senior vice president and MSD UK managing director, has been appointed as President of the Association of the …
FDA approves new erectile dysfunction drug
April 30, 2012Sales and Marketing ED, FDA, Stendra. Pfizer, Vivus, viagra
The FDA has approved Vivus’ erectile dysfunction drug Stendra, and the firm hopes its rapid mode of action will help …
NICE no to GSK’s lupus drug Benlysta
April 27, 2012Sales and Marketing Andrew Dillon, Benlysta, GSK, Lupus, NICE
NICE is still not recommending GlaxoSmithKline’s lupus drug Benlysta, as it believes the treatment is too costly. In its final …
Novartis right to challenge NHS on Avastin use – ABPI chief
April 27, 2012Sales and Marketing ABPI, Lucentis, Whitehead, avastin, wet AMD
The ABPI has declared its support for Novartis in its legal challenge against off-label prescribing in England.The pharma company is …
New head at Bayer’s Animal Health division
April 27, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer Healthcare, Dirk Ehle, animal health
Dr Dirk Ehle has been appointed Head of the Animal Health Division of Bayer. The 42-year-old succeeds Dr Jean-Luc Lowinski, …
Watson buys Actavis to create generics giant
April 27, 2012Sales and Marketing Actavis, Watson, generics
Watson Pharmaceuticals is to buy rival Actavis Group in a move that will create the third largest generics manufacturer in …
Brennan bows to pressure and quits AstraZeneca
April 26, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, David Brennan, Q1, pharma
AstraZeneca’s chief executive David Brennan is to step down from his post following mounting dissatisfaction with his leadership. Brennan, who …
Novartis Q1 earnings slide down
April 26, 2012Sales and Marketing Novartis, Q1, Sandoz, generics, gilenya
Generic competition and problems at a US plant were among the reasons why Novartis’ sales and profit dipped in the …
Text message prompts ‘improve medicines adherence’
April 26, 2012Medical Communications SMS, Text messages, digital communications, medicines adherence
Patients with long-term diseases benefit from having text message reminders to take their medication. This is according to a new …
Two new hep C pills recommended by NICE
April 25, 2012Sales and Marketing Incivo, Janssen, MSD, NICE, Victrelis, hep C
NICE has given its final recommendation for two new hepatitis C pills in an expedited review. Janssen’s Incivo (telaprevir) and …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
